New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
'Movies' with color and music visualize brain activity data in beautiful detail

'Movies' with color and music visualize brain activity data in beautiful detail

byPublic Library of ScienceSimple audiovisualization of wide field neural activity. Credit: Adapted from Thibodeaux et al., 2024, PLOS ONE, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0
Neurology April 09,2024
'Movies' with color and music visualize brain activity data in beautiful detail

'Movies' with color and music visualize brain activity data in beautiful detail

byPublic Library of ScienceSimple audiovisualization of wide field neural activity. Credit: Adapted from Thibodeaux et al., 2024, PLOS ONE, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0
Neurology April 09,2024
Arterial connections found to improve treatment outcomes following stroke

Arterial connections found to improve treatment outcomes following stroke

by Kurt Bodenmüller,University of ZurichVisualization of the blood vessels in the brain of a patient without early venous filling Credit: P. Thurner und Z. Kulcsar, University Hospital ZurichBlo
Neurology April 09,2024
Arterial connections found to improve treatment outcomes following stroke

Arterial connections found to improve treatment outcomes following stroke

by Kurt Bodenmüller,University of ZurichVisualization of the blood vessels in the brain of a patient without early venous filling Credit: P. Thurner und Z. Kulcsar, University Hospital ZurichBlo
Neurology April 09,2024
Protein modifications found to be key influencers in neurodegenerative diseases

Protein modifications found to be key influencers in neurodegenerative diseases

byEcole Polytechnique Federale de Lausanneα-Syn(gS87) PFFs have diminished ability to induce pathology formation, spreading and toxicity in cells and in vivo.a, Primary embryonic hippocamp
Neurology April 09,2024
Protein modifications found to be key influencers in neurodegenerative diseases

Protein modifications found to be key influencers in neurodegenerative diseases

byEcole Polytechnique Federale de Lausanneα-Syn(gS87) PFFs have diminished ability to induce pathology formation, spreading and toxicity in cells and in vivo.a, Primary embryonic hippocamp
Neurology April 09,2024
Protein activation in the brain may protect women against Alzheimer's

Protein activation in the brain may protect women against Alzheimer's

byKarolinska InstitutetGolgi staining of mouse brain tissue. Credit: Silvia Maioli laboratoryA new study at the Karolinska Institute suggests that activation of a certain brain protein can prote
Neurology April 09,2024
Protein activation in the brain may protect women against Alzheimer's

Protein activation in the brain may protect women against Alzheimer's

byKarolinska InstitutetGolgi staining of mouse brain tissue. Credit: Silvia Maioli laboratoryA new study at the Karolinska Institute suggests that activation of a certain brain protein can prote
Neurology April 09,2024
How the brain handles the complexity of chewing

How the brain handles the complexity of chewing

by Béatrice St-Cyr-Leroux,University of MontrealConnectivity of areas involved in chewing and other orofacial behaviors. Credit:Current Opinion in Neurobiology(2023). DOI: 10.1016/j.
Neurology April 09,2024
How the brain handles the complexity of chewing

How the brain handles the complexity of chewing

by Béatrice St-Cyr-Leroux,University of MontrealConnectivity of areas involved in chewing and other orofacial behaviors. Credit:Current Opinion in Neurobiology(2023). DOI: 10.1016/j.
Neurology April 09,2024
Key mechanisms in the synapses of the cerebellum unraveled

Key mechanisms in the synapses of the cerebellum unraveled

byInstitute of Science and Technology AustriaElectron microscope image of neurons in the cerebellum. This slice through the cells in the cerebellum shows a dendritic branch of a Purkinje cell an
Neurology April 09,2024
Key mechanisms in the synapses of the cerebellum unraveled

Key mechanisms in the synapses of the cerebellum unraveled

byInstitute of Science and Technology AustriaElectron microscope image of neurons in the cerebellum. This slice through the cells in the cerebellum shows a dendritic branch of a Purkinje cell an
Neurology April 09,2024
Targeting mitochondria and related protein suggest new therapeutic strategy for treating ALS

Targeting mitochondria and related protein suggest new therapeutic strategy for treating ALS

byNagoya UniversityResearchers have discovered a receptor, sigma-1 receptor (green), and a protein, ATAD3A (red), that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou
Neurology April 09,2024
Targeting mitochondria and related protein suggest new therapeutic strategy for treating ALS

Targeting mitochondria and related protein suggest new therapeutic strategy for treating ALS

byNagoya UniversityResearchers have discovered a receptor, sigma-1 receptor (green), and a protein, ATAD3A (red), that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou
Neurology April 09,2024
DNA treatment could delay paralysis that strikes nearly all patients with ALS

DNA treatment could delay paralysis that strikes nearly all patients with ALS

byUniversity of California - San DiegoAn illustration of the connections between muscle fibers and a motor neuron, the latter of which relies on crucial proteins to create and send signals to th
Neurology April 09,2024
DNA treatment could delay paralysis that strikes nearly all patients with ALS

DNA treatment could delay paralysis that strikes nearly all patients with ALS

byUniversity of California - San DiegoAn illustration of the connections between muscle fibers and a motor neuron, the latter of which relies on crucial proteins to create and send signals to th
Neurology April 09,2024
Immune genes are altered in Alzheimer's patients' blood

Immune genes are altered in Alzheimer's patients' blood

byNorthwestern UniversityCredit:Neuron(2024). DOI: 10.1016/j.neuron.2024.01.013A new Northwestern Medicine study has found the immune system in the blood of Alzheimer's patients
Neurology April 09,2024
Immune genes are altered in Alzheimer's patients' blood

Immune genes are altered in Alzheimer's patients' blood

byNorthwestern UniversityCredit:Neuron(2024). DOI: 10.1016/j.neuron.2024.01.013A new Northwestern Medicine study has found the immune system in the blood of Alzheimer's patients
Neurology April 09,2024
New insights into the protein-mediated motor neuron loss in amyotrophic lateral sclerosis

New insights into the protein-mediated motor neuron loss in amyotrophic lateral sclerosis

by Niigata UniversityUsing novel mouse ALS models, researchers discovered that the pathogenic TDP-43 exhibits distinct propagation patterns in the corticospinal pathway and spinal circuits, providing
Neurology April 09,2024
New insights into the protein-mediated motor neuron loss in amyotrophic lateral sclerosis

New insights into the protein-mediated motor neuron loss in amyotrophic lateral sclerosis

by Niigata UniversityUsing novel mouse ALS models, researchers discovered that the pathogenic TDP-43 exhibits distinct propagation patterns in the corticospinal pathway and spinal circuits, providing
Neurology April 09,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com